GENENTECH, INC for GENENTECH INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 20, 2011 | $1,242,641 | Replaced |
| 4th Quarter - Amendment | Jan 30, 2011 | $1,242,641 | Yes |
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Monitor issues related to export rules and regulations, international patent issues, WTO matters and other international issues impacting biotech and pharmaceuticals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Taxation/Internal Revenue Code TAX
Monitor and report on corporate tax issues; general tax issues and tax extenders
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Copyright/Patent/Trademark CPT
S. 515 & H.R. 1260 - Patent Reform Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Health Issues HCR
Labor HHS appropriations stock piling anti-virals for pandemic influenza; Cancer Research Issues - S.3686/HR__, Labor, HHS Appropriations Bill for FY2011; Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars; H.R.1 - Pandemic influenza funding: H.R. 1105 Omnibus Appropriations Act of 2010, Food Safety Bill, H.R. 4872 Health Care & Education Reconciliation Act of 2010; issues concerning clincial trials; general health care refore (Patient Protection and Affordable Care Act); Congressional oversight issues; FDA approval and enforcement issues; Pandemic preparedness; Tamiflu; Avastin-breast cancer ; following all issues related to health care reform; S.726/HR 1427 - promoting innovation and access to life-saving Medicine Act; HR 1548 - Pathway for Biosimilars Act; General support for Genentech products; monitor and report on issues related to the implementation of health care reform; H.R. 1548 - Pathway for Biosimilars Act;
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | Assoc. Director, Government Affairs |
| DARIN GARDNER | Director, Government Affairs |
| ANNA GRIFFIN | Director, Government Affairs |
| EVAN MORRIS | Vice President, Government Affairs |
| KATHERINE RAAB | Director, Government Affairs |
Medicare/Medicaid MMM
Medicare issues; payment policies for prescription drugs; implementation of H.R. 1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus; physician payment disclosure including S.301; Physician Payments Sunshine Act of 2009; HR 3962, Affordable Health Care for Americans Act; HR 3590, Patitient Protection and Affordable Care Act; H.R> 4872, the Reconciliation Act of 2010; Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act; S. 726/H.R.1427, Promoting innovation and access to Life Savings Medicines Act; HR 3962, Affordable Health Care for America Act; Comparativ effectiveness legislation S. 1213; Patient-Centered Outcomes Research Act of 2009; HR 3200, America's Health Future Act; H.R. 1548-Pathway for Dissimilar Act; Legislative changes in health care reform bill regarding dissimilar; Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act", Affordable Health Choice Act;, American Health Future Act of 2009; Pharmaceutical Import safety legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Budget/Appropriations BUD
Following Issues related to the budget and appropriations process
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Food Industry (safety, labeling, etc.) FOO
Monitor and report on food safety and supply chain issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Homeland Security HOM
Labor HHS Appropriations - S. 3230 & H.R. 3042, Homeland Security Appropriations S.3181 and HR 6947; Congress and Federal Agencies: U.S. House of Representatives: US Senate: HHS; Dept. of Homeland Security; Executive Office of the President; Office of Personnel Management; Dept.of Veteran Affairs
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.